Literature DB >> 15780884

The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.

Karine Gendron1, Dominic Dulude, Guy Lemay, Gerardo Ferbeyre, Léa Brakier-Gingras.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) requires a programmed -1 translational frameshift event to synthesize the precursor of its enzymes, Gag-Pol, when ribosomes from the infected cells translate the full-length viral messenger RNA. Translation of the same RNA according to conventional translational rules produces Gag, the precursor of the structural proteins of the virus. The efficiency of the frameshift controls the ratio of Gag-Pol to Gag, which is critical for viral infectivity. The Moloney murine leukemia virus (MoMuLV) uses a different strategy, the programmed readthrough of a stop codon, to synthesize Gag-Pol. In this study, we investigated whether different forms of the HIV-1 frameshift region can functionally replace the readthrough signal in MoMuLV. Chimeric proviral DNAs were obtained by inserting into the MoMuLV genome the HIV-1 frameshift region encompassing the slippery sequence where the frameshift occurs, followed by the frameshift stimulatory signal. The inserted signal was either a simple stem-loop, previously considered as the stimulatory signal, or a longer bulged helix, now shown to be the complete stimulatory signal, or a mutated version of the complete signal with a three-nucleotide deletion. Although the three chimeric viruses can propagate essentially as the wild-type virus in NIH 3T3 cells, single-round infectivity assays revealed that the infectivity of the chimeric virions is about three to fivefold lower than that of the wild-type virions, depending upon the nature of the frameshift signal. It was also observed that the Gag-Pol to Gag ratio was decreased about two to threefold in chimeric virions. Comparison of the readthrough efficiency of MoMuLV to the HIV-1 frameshift efficiency, by monitoring the expression of a luciferase reporter in cultured cells, revealed that the frameshift efficiencies were only 30-60% of the readthrough efficiency. Altogether, these observations indicate that replacement of the readthrough region of MoMuLV with the frameshift region of HIV-1 results in virions that are replication competent, although less infectious than wild-type MoMuLV. This type of chimera could provide an interesting tool for in vivo studies of novel drugs targeted against the HIV-1 frameshift event.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780884     DOI: 10.1016/j.virol.2005.01.044

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  5 in total

Review 1.  Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious use.

Authors:  John F Atkins; Gary Loughran; Pramod R Bhatt; Andrew E Firth; Pavel V Baranov
Journal:  Nucleic Acids Res       Date:  2016-07-19       Impact factor: 16.971

2.  Modulation of stop codon read-through efficiency and its effect on the replication of murine leukemia virus.

Authors:  Eszter Csibra; Ian Brierley; Nerea Irigoyen
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

Review 3.  Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV.

Authors:  Ian Brierley; Francisco J Dos Ramos
Journal:  Virus Res       Date:  2005-11-28       Impact factor: 3.303

4.  Cellular senescence limits translational readthrough.

Authors:  Neylen Del Toro; Frédéric Lessard; Jacob Bouchard; Nasrin Mobasheri; Jordan Guillon; Sebastian Igelmann; Sarah Tardif; Tony Buffard; Véronique Bourdeau; Léa Brakier-Gingras; Gerardo Ferbeyre
Journal:  Biol Open       Date:  2021-12-02       Impact factor: 2.422

Review 5.  Frameshifting RNA pseudoknots: structure and mechanism.

Authors:  David P Giedroc; Peter V Cornish
Journal:  Virus Res       Date:  2008-07-25       Impact factor: 3.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.